Six year follow-up of a child with Bartter syndrome.
D000450:Aldosterone / Q000097:blood / Q000652:urine; D000471:Alkalosis / Q000378:metabolism; D000804:Angiotensin II; D001706:Biopsy; D001794:Blood Pressure / Q000187:drug effects; D002675:Child, Preschool; D004035:Diet Therapy; D005260:Female; D005500:Follow-Up Studies; D006130:Growth Disorders / Q000188:drug therapy; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D006965:Hyperplasia; D006984:Hypertrophy; D007008:Hypokalemia / Q000378:metabolism; D007606:Juxtaglomerular Apparatus / Q000378:metabolism*; D007671:Kidney Concentrating Ability; D007674:Kidney Diseases / Q000378:metabolism*; D009638:Norepinephrine; D011188:Potassium / Q000627:therapeutic use; D012083:Renin / Q000097:blood; D012636:Secretory Rate; D012965:Sodium Chloride / Q000627:therapeutic use; D013148:Spironolactone / Q000494:pharmacology / Q000627:therapeutic use; D013577:Syndrome; D014667:Vasopressins
D014667:Vasopressins; D000804:Angiotensin II; D013148:Spironolactone; D012965:Sodium Chloride; D000450:Aldosterone; D012083:Renin; D011188:Potassium; D009638:Norepinephrine